Generative AI isn’t going away, that’s for sure. But that doesn’t mean we have to live with the most dangerous and problematic aspects of gen-AI. Here’s four things that need to happen for generative ...

Biogen and Ionis plan to share data at the Alzheimer’s Association International Conference in July. (Getty Images) A phase 2 trial of Biogen and Ionis Pharmaceuticals’ tau-targeting candidate missed ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form ...

Veronica Beagle is the managing editor for Education at Forbes Advisor. She completed her master’s in English at the University of Hawai‘i at Mānoa. Before coming to Forbes Advisor she worked on ...